Techorizon to Launch Innovative TH-eClinical Suite at DIA Annual Meeting
Techorizon will launch the TH-eClinical suite of clinical research products at a press event at DIA.
Techorizon
, a leading provider of clinical technology solutions, will launch the TH-eClinical suite of clinical research products at a press event on Tuesday, June 17, at the Drug Information Association Annual Meeting (DIA) in San Diego.
The TH-eClinical suite consists of four integrated research modules, including TH-eCRF (21 CFR Part 11 compliant electronic case report form), TH-eDiary (flexible ePRO patient diary), TH-eSurvey (intuitive electronic questionnaire) and TH-eLearning (a fully validated remote learning application). All applications can be fully integrated or deployed independently and are accessible securely in real time via computer, tablet or smartphone connection with the Cloud.
“TH-eClinical and its individual applications provide a flexible, highly advanced and cost-effective alternative for global research and development,” said Silvio Severini, managing director of Techorizon. “Each TH-eClinical application can be quickly tailored to meet the unique requirements of individual clients and data is validated to GAMP 5 standards and securely archived within our own state-of-the-art infrastructure.”
Part of the
CROMSOURCE
group of companies, Techorizon combines two decades of clinical development knowledge with a team of health information technology (HIT) experts to help clients improve outcomes and shorten development timelines at a lower cost than competing technologies.
Visitors to CROMSOURCE and Techorizon’s Booth 710 at DIA will see demonstrations of TH-eClinical and be able to register for a chance to win use of a TH-eClinical application in a future project.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
